C-Bridge Capital Investment Advisor, Limited is a Hong Kong company(Private Company Limited by Shares), company number is 2038266, registered address is SUITES 3306-3307 TWO EXCHANGE SQUARE, 8 CONNAUGHT ROAD CENTRAL, HONG KONG(changed on February 11, 2019), former address is Room 902 Chinachem Tower, 9/F, 34-37 Connaught Road Central Hong Kong. Its email is 25491073. Its business number is 62755766.
In our records, C-Bridge Capital Investment Advisor, Limited changed its secretary 1 times, first secretary is KL SECRETARIES LIMITED, address is Room 902 Chinachem Tower, 9/F, 34-37 Connaught Road Central Hong Kong, now the secretary is KL SECRETARIES LIMITED(ID 0822669), telephone number is 2549 1073, fax number is 2549 1629, address is ROOM 819-820 8/F CHINA INSURANCE GROUP BUILDING 141 DES VOEUX ROAD CENTRAL, HONG KONG.
C-Bridge Capital Investment Advisor, Limited has 1 founders, namely C-Bridge Capital GP, Ltd, address is PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands, owns 1 shares of the company.
C-Bridge Capital Investment Advisor, Limited has 1 first directors, namely FU, WEI, address is Xiangmei Garden, Pudong New District, Shanghai, China.
C-Bridge Capital Investment Advisor, Limited now has 1 shareholder, named C-Bridge Capital Investment Management, Ltd. (Address: PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands), owns 1 shares of the company.
C-Bridge Capital Investment Advisor, Limited has 1 current directors, namely FU, WEI.
FU, WEI, SINGAPORE residents, previous residential address is Xiangmei Garden, Pudong New District, Shanghai, China, changed to Xiangyi Garden, Building 28, No. 168 East Shiquan Road, Putuo District, Shanghai, China. As of today, FU, WEI, director of C-Bridge Capital Investment Advisor, Limited, has 50 Hong Kong company.
|
Company Name |
Company Number |
|
Affamed Therapeutics (HK) Limited |
2788551 |
|
C-Bridge Capital Investment Advisor, Limited |
2038266 |
|
CBC FW Investment Limited |
2527569 |
|
CBC Group (HK) Limited |
2788564 |
|
CBC II Investment Eight Limited |
2534797 |
|
CBC II Investment Eleven Limited |
2631571 |
|
CBC II Investment Four Limited |
2451860 |
|
CBC II Investment One Limited |
2381417 |
|
CBC II Investment Seven Limited |
2534792 |
|
CBC II Investment Thirteen Limited |
2709091 |
|
CBC II Investment Three Limited |
2438054 |
|
CBC IV Investment Eight Limited |
2798683 |
|
CBC IV Investment Eleven Limited |
2824825 |
|
CBC IV Investment Five Limited |
2774414 |
|
CBC IV Investment Four Limited |
2774096 |
|
CBC IV Investment Fourteen Limited |
2925904 |
|
CBC IV Investment Nine Limited |
2798678 |
|
CBC IV Investment Ten Limited |
2812115 |
|
CBC IV Investment Twelve Limited |
2824827 |
|
CBC Investment Fifteen Limited |
2381421 |
|
CBC Investment Ten Limited |
2287464 |
|
CBC Investment Twelve Limited |
2409920 |
|
CBC SPVII LIMITED |
2123574 |
|
CBC SPVIII LIMITED |
2159128 |
|
CBC SPVIV LIMITED |
2179247 |
|
CBC SPVV LIMITED |
2179250 |
|
CBC V Investment Two Limited |
2760718 |
|
CBio-X Therapeutics (HK) Limited |
3064156 |
|
CVC Management (HK) Limited |
2856835 |
|
EverBridge Medical (HK) Limited |
3082342 |
|
EverInsight Therapeutics Limited |
2631632 |
|
EverOnc Medicines Limited |
2534799 |
|
Everest Medicines II (HK) Limited |
2780544 |
|
Everest Medicines Limited |
F0028221 |
|
I-Bridge Capital Investment Advisor, Limited |
2304421 |
|
I-Mab |
F0024621 |
|
IBC Investment Eight Limited |
2431786 |
|
IBC Investment Five Limited |
2345070 |
|
IBC Investment Four Limited |
2345058 |
|
IBC Investment One Limited |
2313290 |
|
IBC Investment Seven Limited |
2348047 |
|
IBC Investment Six Limited |
2345087 |
|
IBC Investment Two Limited |
2327638 |
|
InxMed Biotechnology Limited |
2327654 |
|
Jadeite Medicines (HK) Limited |
2934137 |
|
Nuance Pharma Limited |
2804789 |
|
Rennuo Hospital Group (HK) Limited |
2774090 |
|
Royalty Bridge Investment Management, Limited |
2901089 |
|
Royalty Bridge Investment One Limited |
2943411 |
|
Yaneng Bioscience (HK) Limited |
3076002 |